Status:

COMPLETED

Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

Lead Sponsor:

AstraZeneca

Conditions:

Schizophrenia

Bipolar Disorder

Eligibility:

All Genders

18+ years

Brief Summary

Non-interventional, prospective study to validate Spanish version of TOOL questionnaire in patients with schizophrenia and bipolar disorder under antipsychotic treatment

Eligibility Criteria

Inclusion

  • Schizophrenia and bipolar disorder (DSM-IV criteria)
  • Stabilized out-patients
  • Treated with the same oral antipsychotic at least in the last month

Exclusion

  • Participation in another clinical trial within 6 months prior to enrolment into this study
  • Administration of a depot antipsychotic medication

Key Trial Info

Start Date :

March 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2008

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT00692133

Start Date

March 1 2008

End Date

August 1 2008

Last Update

December 10 2010

Active Locations (32)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (32 locations)

1

Research Site

Vitoria-Gasteiz, Alava, Spain

2

Research Site

Palma, Balearic Islands, Spain

3

Research Site

Gavà, Barcelona, Spain

4

Research Site

Burgos, Burgos, Spain